These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9367668)

  • 1. A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women.
    Sirtori P; Sosio C; Polo RM; Tenni R; Rubinacci A
    Pharmacol Res; 1997 Sep; 36(3):229-35. PubMed ID: 9367668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.
    Marabini R; Sirtori P; Chionna R; Barzizza L; Rubinacci A
    J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis.
    Bettica P; Taylor AK; Talbot J; Moro L; Talamini R; Baylink DJ
    J Clin Endocrinol Metab; 1996 Feb; 81(2):542-6. PubMed ID: 8636265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.
    Guerrero R; Diaz Martin MA; Diaz Diego EM; Disla T; Rapado A; de la Piedra C
    Osteoporos Int; 1996; 6(4):297-302. PubMed ID: 8883118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary galactosyl-hydroxylysine in postmenopausal osteoporotic women: A potential marker of bone fragility.
    Lo Cascio V; Bertoldo F; Gambaro G; Gasperi E; Furlan F; Colapietro F; Lo Cascio C; Campagnola M
    J Bone Miner Res; 1999 Aug; 14(8):1420-4. PubMed ID: 10457275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover.
    Raisz L; Smith JA; Trahiotis M; Fall P; Shoukri K; Digennaro J; Sacco-Gibson N
    Osteoporos Int; 2000; 11(7):615-20. PubMed ID: 11069196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
    Bettica P; Moro L; Robins SP; Taylor AK; Talbot J; Singer FR; Baylink DJ
    Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodelling in postmenopausal women.
    Sirtori P; Sosio C; Resmini G; Rubinacci A
    Pharmacol Res; 1996 Jun; 33(6):353-9. PubMed ID: 8971958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an oral calcium load on urinary markers of collagen breakdown.
    Rubinacci A; Divieti P; Polo RM; Zampino M; Resmini G; Tenni R
    J Endocrinol Invest; 1996 Dec; 19(11):719-26. PubMed ID: 9061504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary output of hydroxylysine glycosides and pyridinium cross-links in detecting rat bone collagen turnover rate.
    Grazioli V; Alfano M; Stenico A; Casari E
    FEBS Lett; 1996 Jun; 388(2-3):134-8. PubMed ID: 8690072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover markers and bone density across the menopausal transition.
    Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
    Hassager C; Colwell A; Assiri AM; Eastell R; Russell RG; Christiansen C
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):45-50. PubMed ID: 1424192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D; Schlemmer A; Johansen JS; Gineyts E; Christiansen C; Delmas PD
    J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared.
    Bettica P; Bevilacqua M; Vago T; Masino M; Cucinotta E; Norbiato G
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3034-9. PubMed ID: 9284739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.